Brief: Aroa Biosurgery Maintains FY25 Normalised EBITDA Profit Guidance
24/07/2024 02:16
July 24 (Reuters) - Aroa Biosurgery Ltd ARX.AX :
* FY25 NORMALISED EBITDA PROFIT GUIDANCE MAINTAINED
* FY25 REVENUE GUIDANCE MAINTAINED AT NZ$80-87 MILLION
Further company coverage: ARX.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aroa Biosurgery
See all newsAustralia-listed Aroa Biosurgery climbs as annual earnings beat guidance
Brief: Aroa Biosurgery Posts Adjusted EBITDA Of NZ$12.6 Million
Aroa Biosurgery climbs as prelim annual results beat outlook
Brief: Aroa Biosurgery Posts FY26 Prelim Total Revenue Of NZ$104 Million
Brief: Aroa Biosurgery Says Expects FY26 Revenue At Upper End Of NZ$92-100 Million